TwinBeech Capital’s Haemonetics HAE Stock Holding History

TwinBeech Capital’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,633	Closed	-$205K	–	506
2026 Q1	$205K	Buy	+3,633	New	+$237K	0.02%	513
2025 Q4	–	Sell	-16,804	Closed	-$819K	–	701
2025 Q3	$819K	Buy	+16,804	New	+$1.04M	0.03%	342
2024 Q4	–	Sell	-4,487	Closed	-$361K	–	738
2024 Q3	$361K	Buy	+4,487	New	+$362K	0.01%	606
2024 Q1	–	Sell	-41,396	Closed	-$3.54M	–	693
2023 Q4	$3.54M	Buy	+41,396	New	+$3.58M	0.06%	323
2023 Q3	–	Sell	-14,982	Closed	-$1.28M	–	743
2023 Q2	$1.28M	Buy	+14,982	New	+$1.27M	0.03%	429
2023 Q1	–	Sell	-65,972	Closed	-$5.19M	–	731
2022 Q4	$5.19M	Buy	+65,972	New	+$5.3M	0.1%	251
2022 Q1	–	Sell	-22,426	Closed	-$1.19M	–	599
2021 Q4	$1.19M	Buy	+22,426	New	+$1.37M	0.07%	314
2021 Q2	–	Sell	-8,350	Closed	-$927K	–	526
2021 Q1	$927K	Buy	8,350 +6,234	+295%	+$771K	0.14%	202
2020 Q4	$251K	Buy	+2,116	New	+$228K	0.04%	382
2020 Q1	–	Sell	-10,902	Closed	-$1.25M	–	367
2019 Q4	$1.25M	Buy	+10,902	New	+$1.32M	0.36%	88

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TwinBeech Capital's HAE Position: Q2 2026 in Review

TwinBeech Capital sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 3,633 shares — an estimated $205K sold.

TwinBeech Capital first reported a position in HAE in Q4 2019 and held it in 10 quarters. The position peaked at $5.19M in Q4 2022. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

TwinBeech Capital reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
TwinBeech Capital sold 3,633 Haemonetics shares in Q2 2026, an estimated $205K.
TwinBeech Capital first reported a position in Haemonetics in Q4 2019 and held it in 10 quarters.
TwinBeech Capital's Haemonetics position peaked at $5.19M in Q4 2022.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.